Furthermore, estrogen can increase SDF1 (also known as CXCL12) production in cancer cells and the TME, while the SDF1/CXCR4 signaling pathway has been shown to activate ER and promote hormone-independent tumor growth [87]. This evidence concerns the gene CXCL12 and neoplasm.